A detailed history of Seven Bridge Financial Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 999 shares of VRTX stock, worth $474,604. This represents 0.1% of its overall portfolio holdings.

Number of Shares
999
Previous 999 -0.0%
Holding current value
$474,604
Previous $417,000 12.23%
% of portfolio
0.1%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$407.69 - $446.08 $136,576 - $149,436
-335 Reduced 25.11%
999 $417,000
Q4 2023

Jan 22, 2024

BUY
$343.0 - $410.68 $60,025 - $71,869
175 Added 15.1%
1,334 $542,000
Q2 2023

Jul 26, 2023

SELL
$314.42 - $351.91 $47,163 - $52,786
-150 Reduced 11.46%
1,159 $407,000
Q1 2023

Apr 20, 2023

SELL
$283.23 - $323.1 $9,913 - $11,308
-35 Reduced 2.6%
1,309 $412,000
Q4 2022

Jan 26, 2023

SELL
$285.76 - $321.48 $4,572 - $5,143
-16 Reduced 1.18%
1,344 $0
Q2 2022

Jul 12, 2022

SELL
$234.96 - $292.55 $21,146 - $26,329
-90 Reduced 6.21%
1,360 $383,000
Q1 2022

Apr 15, 2022

SELL
$221.42 - $260.97 $46,498 - $54,803
-210 Reduced 12.65%
1,450 $378,000
Q4 2021

Jan 20, 2022

SELL
$177.01 - $223.45 $336,141 - $424,331
-1,899 Closed
0 $0
Q4 2021

Jan 20, 2022

BUY
$177.01 - $223.45 $293,836 - $370,927
1,660 New
1,660 $365,000
Q3 2021

Oct 14, 2021

SELL
$181.39 - $202.99 $79,086 - $88,503
-436 Reduced 18.67%
1,899 $344,000
Q2 2021

Jul 26, 2021

BUY
$187.49 - $221.1 $15,374 - $18,130
82 Added 3.64%
2,335 $471,000
Q1 2021

Apr 20, 2021

BUY
$207.02 - $241.31 $116,966 - $136,340
565 Added 33.47%
2,253 $484,000
Q4 2020

Jan 19, 2021

BUY
$207.01 - $276.09 $349,432 - $466,039
1,688 New
1,688 $399,000
Q3 2020

Oct 22, 2020

SELL
$255.65 - $303.1 $341,548 - $404,941
-1,336 Closed
0 $0
Q3 2019

Oct 09, 2019

BUY
$166.23 - $187.09 $222,083 - $249,952
1,336 New
1,336 $226,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Seven Bridge Financial Group, LLC Portfolio

Follow Seven Bridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.